{"schema_version":"secwatch.filing_event.v1","accession":"0001641172-25-008956","form_type":"8-K","ticker":"TELO","cik":"0001971532","company_name":"Telomir Pharmaceuticals, Inc.","filed_at":"2025-05-07T23:59:59+00:00","discovered_at":"2026-05-14T18:02:50.598941+00:00","generated_at":"2026-05-22T09:23:05.412396+00:00","sec_items":["8.01"],"event_type":"other_material","sentiment":"positive","materiality_score":0.6,"calibrated_materiality_score":0.6,"confidence":"high","headline":"Telomir-1 reverses cellular decline markers in human cell lines; supports autism and spasmodic dysphonia programs","bullets":["New preclinical data show Telomir-1 improved cell viability under stress and boosted mitochondrial function in human cell lines.","Telomir-1 reduced reactive oxygen species (ROS) and restored calcium signaling, limiting oxidative damage and maintaining cellular communication.","Telomir-1 protected cells from iron- and copper-induced toxicity, which are linked to ROS formation and accelerated aging.","Findings provide mechanistic foundation for new research initiatives in autism spectrum disorder (ASD) and spasmodic dysphonia (SD)."],"urls":{"canonical":"https://secwatch.observer/filing/0001641172-25-008956","json":"https://secwatch.observer/filing/0001641172-25-008956.json","markdown":"https://secwatch.observer/filing/0001641172-25-008956.md","text":"https://secwatch.observer/filing/0001641172-25-008956.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1971532/000164117225008956/0001641172-25-008956-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1971532/000164117225008956/form8-k.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-05-22T09:23:05.412396+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}